card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
WE'RE HIRING

Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search jobs website-featured_jpg-2213_cheerful-young-colleagues-using-laptop
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download card-3242_Scientist using tablet while colleagues working behind
2768_CentralLaboratory

Central laboratories

Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider.
2502_Abstract-big-data-connection-technology-concept

Digital Technologies

Labmatrix® is an industry-leading solution developed to address some of the biggest challenges related to clinical trial sample management.
182_genomics-1

Genomics

We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development. Our industry-leading team advances research by delivering scientific insights that help clients maximize the value of their data.

3233_discovery

Discovery Sciences

Our labs bring expertise in protein production, antibody discovery, and immunogenicity to help you select the most promising candidates and reduce risk as you move toward IND-enabling studies.
3253_bioa

Biosciences

One of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies worldwide.
card-3275_Young scientist works in modern laboratory

Specialty immunoassays

a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.
3214_vaccines

Vaccines

Combining cutting-edge technology platforms and state-of-the-art laboratories with over 35 years of clinical vaccine development.
card-3242_Scientist using tablet while colleagues working behind

Digital innovation

We have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. We’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.
2768_therapeutic_expertise

Therapeutic expertise
Contact Us
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Driving innovation in obesity and endocrinology clinical development

IQVIA Laboratories offers the scientific leadership and global infrastructure to help you move faster. With over 150 therapeutics currently in clinical phases, speed and precision are critical.  Because we understand and have vast experience in these complex disease states, we offer operational efficiency, regulatory expertise, and advanced instrumentation that can generate high-quality data faster, so you can be first to market with effective therapies.

 obesity and endocrinology
Home / Therapeutic Expertise / Obesity and Endocrinology
Advance your obesity and endocrinology drug development with the power of IQVIA Laboratories

IQVIA Laboratories is driving innovation in obesity drug development. Our expertise spans from complex biomarker quantification to high-throughput assay validation, delivering accurate, reproducible data that drives confident decision-making.

 

We understand that therapies targeting obesity, Type 2 Diabetes (T2D) and broader endocrine disorders often present unique bioanalytical challenges due to their complex molecular structures and mechanisms of action. That’s why we apply advanced pharmacokinetic (PK) and pharmacodynamic (PD) profiling, along with robust ADME (absorption, distribution, metabolism, excretion) strategies.

 

With a rigorous, science-driven approach, IQVIA Laboratories ensures precision, reproducibility and speed across every stage of your drug development program—empowering you to bring life-changing therapies to patients faster.

The Future of Obesity

Almost 2/3 of adults are estimated to be overweight or obese by 2050, at 3.8 billion*

Obesity rising in children and adolescents: 121% forecast increase for the next 30 years*

IQVIA identifies key trends and research strategies and develops thought leadership to share obesity insights on this pervasive global health challenge.

Learn more

‘Source: The Lancet (2025): Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Copyright © 2025 IQVIA. All rights reserved.

IQVIA Laboratories’ Obesity Portfolio

Obesity-specific trials

Patients supported

biosamples managed

What makes IQVIA Laboratories a leader in obesity and endocrinology drug development?

Our scientific expertise and laboratory services are designed to support the full lifecycle of obesity and endocrinology drug development.

  • Therapeutic and analytical expertise in key endocrine, metabolic indications, and lipid analysis
  • Clinical laboratory assessments, including standard safety, biomarkers, PK and immunogenicity
  • Assay Validation: Ensure accuracy and compliance with customized assay validation for reliable bioanalytical results.
  • ADME Metabolism Exploration: Gain deep insights into drug absorption, distribution, metabolism, and excretion with expert ADME profiling.
  • Regulated LC-MS Bioanalysis: Achieve high-sensitivity, regulatory-compliant LC-MS bioanalysis.
  • Soluble Protein Testing: Accurately measure protein solubility and binding interactions to support pharmacokinetic evaluations.
  • Translational Biomarker Solutions: Bridge preclinical and clinical research with biomarker strategies that drive precision medicine.
Our therapeutic modalities
  • Large and small molecules
    • GLP-1, GIP, glucagon agonists
    • MC4R
    • Fixed combination therapies
  • Antibodies and antibody-drug conjugates (ADCs)
  • Proteins
  • Peptides
  • Oligonucleotides 
    • ASO
    • siRNA
4525_Molecular Structures, Peptide Hormones Insulin Glucagon and Leptin
Our expert-led methodologies

IQVIA Laboratories provides both regulated and non-regulated bioanalytical services using advanced liquid chromatography-mass spectrometry (LC-MS) and high-resolution mass spectrometry (HRMS) platforms. These services are essential for supporting ADME studies—studying the absorption, distribution, metabolism and excretion of a drug—from phase I safety studies through dosing studies in phase II and III studies.
What are the capabilities needed to bring an obesity drug to market?
Research and discovery bioanalysis
Need fast, flexible data to guide early decisions? Our non-regulated bioanalysis services are ideal for:
  • In silico and in vitro lead optimization and candidate screening
  • Exploratory ADME profiling
  • Biomarker discovery and metabolite identification
  • High-throughput soluble protein immunoassays for broad biomarker discovery
  • Rapid method development and feasibility studies
  • These services help accelerate timelines and reduce risk in early development.
GLP-compliant bioanalysis

If you're looking for GLP-compliant assays for regulatory submissions, our regulated services are designed to meet the highest standards. We provide:

  • Validated LC-MS/HRMS methods for small molecules and biologics
  • Full compliance with FDA, EMA, and ICH guidelines
  • Support for preclinical toxicology, first-in-human (FIH) studies, and clinical PK/PD assessments including multiplexed immunoassays
  • High-quality, reproducible data for regulatory filings
  • In vivo drug-drug interaction (DDI) study support. Click to see our full list of non-proprietary methods.
IQVIA Laboratories offers a full spectrum of lab services, from discovery to commercialization

discovery-to-commercialization-full-lab-svs

 

*Biosciences’ services
Frequently Asked Questions
Can IQVIA Laboratories develop and validate custom bioanalytical assays for my program?

Yes. IQVIA Laboratories offers full-service assay development and validation tailored to your molecule and study needs.
Can IQVIA Laboratories support both small and large molecule drug development?

Yes. Our LC-MS and HRMS platforms are optimized for a wide range of therapeutic modalities, including peptides, proteins, and complex biologics.
What lab services does IQVIA Laboratories offer for obesity and endocrinology drug development?

We provide LC-MS-based bioanalysis, biomarker validation, PK/PD profiling, and assay development tailored to obesity and metabolic therapies.
Can IQVIA Laboratories support endocrine clinical trials?

Yes. We support trials for thyroid, adrenal and pituitary disorders, as well as diabetes and hormonal therapies.
How does IQVIA Laboratories ensure data quality and regulatory compliance?

Our labs follow GLP/GCP standards and are equipped for FDA, EMA, and ICH-compliant submissions.
Ready to accelerate your obesity or endocrinology program?

Contact IQVIA Laboratories today to learn how our expertise and services can support your regulated and non-regulated bioanalysis needs.

Related Insights

White Paper
Mass Matters: Expertise in Addressing Drug Bioanalysis for T2D and Obesity with LC-MS
Factsheet
Accelerating Precision Bioanalysis for Obesity and Type 2 Diabetes Drug Development

 See All